Evidence map›Paper›PMID 38842497›Full record

ArticleThe Journal of infectious diseases2024

Dengue NS1 Antibodies Are Associated With Clearance of Viral Nonstructural Protein-1.

Michelle Premazzi Papa, Evelyn Mendoza-Torres, Peifang Sun, Liliana Encinales, Joseph Goulet, Gabriel Defang, Jani Vihasi, Ying Cheng, Karol Suchowiecki, Wendy Rosales and 12 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Dengue NS1 as a Driver of Immune-Mediated Pathogenesis.Tropical medicine and infectious disease · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Michelle Premazzi PapaDepartment of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington, District of Columbia, USA.
Evelyn Mendoza-TorresGrupo de Investigación Avanzada en Biomedicina, Universidad Libre de Colombia, Barranquilla, Atlántico, Colombia.
Peifang SunDirectorate for Defense Infectious Diseases, Naval Medical Research Center, Silver Spring, Maryland, USA.
Liliana EncinalesDepartment of Medicine, Allied Research Society Colombia, Barranquilla, Atlántico, Colombia.
Joseph GouletDepartment of Emergency Medicine, Yale School of Medicine, West Haven, Connecticut, USA.
Gabriel DefangDirectorate for Defense Infectious Diseases, Naval Medical Research Center, Silver Spring, Maryland, USA.
Jani VihasiHenry Jackson Foundation, Bethesda, Maryland, USA.
Ying ChengLeidos, Reston, Virginia, USA.
Karol SuchowieckiDepartment of Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia, USA.
Wendy RosalesGrupo de Investigación Avanzada en Biomedicina, Universidad Libre de Colombia, Barranquilla, Atlántico, Colombia.
Richard AmdurDepartment of Quantitative Intelligence, Institute for Health Systems Science, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
Alexandra Porras-RamirezGrupo de Medicina Comunitaria y Salud Colectiva, Universidad El Bosque, Bogotá, Colombia.
Alejandro Rico-MendozaGrupo de Medicina Comunitaria y Salud Colectiva, Universidad El Bosque, Bogotá, Colombia.
Carlos Herrera GomezDepartment of Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia, USA.
Samuel NicholesDepartment of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington, District of Columbia, USA.
Ivan ZuluagaClínica Iberoamérica, Universidad Libre de Barranquilla, Barranquilla, Atlántico, Colombia.
Liam HalsteadDepartment of Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia, USA.
Scott HalsteadDepartment of Medicine, Infectious Diseases Division, Uniformed Services University, Bethesda, Maryland, USA.
Gary SimonDepartment of Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia, USA.
Kevin PorterDirectorate for Defense Infectious Diseases, Naval Medical Research Center, Silver Spring, Maryland, USA.
Rebecca M LynchDepartment of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington, District of Columbia, USA.ORCID 0000-0002-7188-8073
Aileen Y ChangDepartment of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington, District of Columbia, USA.

Funding

Clinical and Translational Science Institute at Childrens NationalUL1TR001876 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI BELL, MICHAEL J · 2016 to 2021
$25.6M
Clinical and Translational Science Institute at Childrens National-Mentored Career Development CoreKL2TR001877 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI LUBAN, NAOMI L · 2016 to 2020
$2.0M
NCATS NIH HHS KL2 TR001877NCATS NIH HHS UL1 TR001876NIH HHS UL1TR001876
6 · The paper itself

Abstract

backgroundDengue vascular permeability syndrome is the primary cause of death in severe dengue infections. The protective versus potentially pathogenic role of dengue nonstructural protein-1 (NS1) antibodies are not well understood. The main goal of this analysis was to characterize the relationship between free NS1 concentration and NS1 antibody titers in primary and secondary dengue infection to better understand the presence and duration of NS1 antibody complexes in clinical dengue infections.

methodsHospitalized participants with acute dengue infection were recruited from Northern Colombia between 2018 and 2020. Symptom assessment, including dengue signs and symptoms, chart review, and blood collection, was performed. Primary versus secondary dengue was assessed serologically. NS1 titers and anti-NS1 antibodies were measured daily.

resultsPatients with secondary infection had higher antibody titers than those in primary infection, and there was a negative correlation between anti-NS1 antibody titer and NS1 protein. We demonstrate that in a subset of secondary infection, there were indeed NS1 antigen-antibody complexes on the admission day during the febrile phase that were not detectable by the recovery phase. Furthermore, dengue infection status was associated with higher circulating sialidases. DISCUSSION: The negative correlation between antibody and protein suggests that antibodies may play a role in clearing this viral protein.

Indexed as

Antibodies, ViralDengueDengue VirusViral Nonstructural ProteinsAdolescentAdultAntigen-Antibody ComplexColombiaFemaleHumansMaleMiddle AgedYoung AdultAntibodies, ViralAntigen-Antibody ComplexViral Nonstructural Proteinsacid dissociationantigen-antibody complexesdengueneutralizationNS1 antibodiessialidase 2

Identifiers

PMID38842497
PMCPMC11646586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.